Aravasc, Inc.
Sunnyvale, CA
- UEI
- C5QVPEJYM4K8
- CAGE
- 47XX7
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1520 Samedra St, Sunnyvale, CA 94087, USA
- Website
- aravasc.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase I award | National Cancer Institute (NIH) | $200,000 | |
| Multifunctional drug-delivery stent with nanoporous coat | National Cancer Institute (NIH) | $199,999 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| The Leland Stanford Junior University | 75N93020C00054 | $80,132 | |
| The Leland Stanford Junior University | 75N93020C00054 | $108,800 |
Grant awards
Quick answers
Is Aravasc, Inc. registered in SAM.gov?
Yes. Aravasc, Inc.'s SAM.gov registration is active through May 28, 2027.
What is Aravasc, Inc.'s CAGE code?
Aravasc, Inc.'s CAGE code is 47XX7, and its Unique Entity ID (UEI) is C5QVPEJYM4K8.
What is Aravasc, Inc.'s most recent federal award?
Aravasc, Inc.'s most recent federal contract award is Sbir phase I award (HHSN261201100053C), from National Cancer Institute (NIH), on September 27, 2011.
On GovTribe
See Aravasc, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors